https://www.selleckchem.com/pr....oducts/tucidinostat-
A diagnostic-therapeutic pathway for patients with kidney stone disease was first published on this Journal in 2010. The present contribution aims at amending and updating the article published exactly ten years ago, to serve as an easy-to-use reference and to guide good clinical practice in this field.Questo documento è stato tradotto dall'inglese a nome dell'ERBP (European Renal Best Practice), un organo ufficiale dell'ERA-EDTA (European Renal Association - European Dialysis and Transplant Association), e si basa su una
Like
Comment
Share
